Time for you.
TASCENSO ODT® is a multiple sclerosis (MS) treatment with your needs in mind. It is the same proven fingolimod you might be familiar with, but it comes in a unique orally disintegrating tablet (ODT) formulation1, accompanied by Cycle Vita™, our dedicated support platform.
It is a prescription medicine used to treat relapsing forms of MS, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older.1
NOT ACTUAL PATIENT
Support
We know that life-changing treatments need a support system which is tailored to the unique challenges you might be facing. That’s why we created Cycle Vita, our dedicated hub support program, which delivers individualized product support* at every step. Including:
- Financial Assistance
- Medication Adherence Support
- Bridge Program
- TASCENSO Time Program (baseline assessments and first dose observations)
Product
TASCENSO ODT is the same proven fingolimod you might be familiar with, but it comes in a unique orally disintegrating tablet formulation.1
- The first MS treatment available as an easy-to-swallow, orally disintegrating tablet
- Dissolves on the tongue in seconds
- Taken once-daily, with or without food and with or without water
- No special storage conditions required, stored at room temperature
References
1. TASCENSO ODT (fingolimod). Prescribing Information. Cycle Pharmaceuticals Ltd.
*Some areas of support may not be accessible to all patients. Eligibility criteria may apply to ensure compliance with all applicable federal and state requirements, and benefits may be limited to commercially insured patients only. For more detailed information about eligibility, terms and conditions, please contact the Cycle Vita team at +1 (888) 360-8482.